Clinical Scorecard: The Impact of Medicaid Expansion on Mortality Rates in Colorectal Cancer Patients

At a Glance

Key Highlights

• Colorectal cancer is a leading cause of cancer-associated morbidity and mortality in the US.
• Medicaid expansion has been associated with improved cancer screening and treatment utilization.
• Social determinants of health significantly influence colorectal cancer outcomes.
• The study utilized a difference-in-differences framework to assess mortality rates.
• Racial and ethnic disparities in colorectal cancer outcomes were a focus of the study.

Guideline-Based Recommendations

Diagnosis

• Histologically confirm colorectal cancer diagnosis.
• Utilize AJCC TNM classifications for staging.

Management

• Ensure access to preventive services and evidence-based treatment through Medicaid.

Monitoring & Follow-up

• Track overall mortality and treatment patterns post-ACA implementation.

Risks

• Consider socioeconomic and racial/ethnic factors that may affect disease stage and outcomes.

Patient & Prescribing Data

Adults aged 40 to 64 years with colorectal cancer.

Access to definitive treatment may improve with Medicaid expansion.

Clinical Best Practices

• Encourage early detection through screening.
• Address social determinants of health in treatment planning.
• Monitor disparities in treatment and outcomes among different racial and ethnic groups.

Related Resources & Content

• National Cancer Database
• Patient Protection and Affordable Care Act